| Ident. | Authors (with country if any) | Title |
|---|
| 000011 (2020) |
Matthieu Million [France] ; Jean-Christophe Lagier [France] ; Philippe Gautret [France] ; Philippe Colson [France] ; Pierre-Edouard Fournier [France] ; Sophie Amrane [France] ; Marie Hocquart [France] ; Morgane Mailhe [France] ; Vera Esteves-Vieira [France] ; Barbara Doudier [France] ; Camille Aubry [France] ; Florian Correard [France] ; Audrey Giraud-Gatineau [France] ; Yanis Roussel [France] ; Cyril Berenger [France] ; Nadim Cassir [France] ; Piseth Seng [France] ; Christine Zandotti [France] ; Catherine Dhiver [France] ; Isabelle Ravaux [France] ; Christelle Tomei [France] ; Carole Eldin [France] ; Hervé Tissot-Dupont [France] ; Stéphane Honoré [France] ; Andreas Stein [France] ; Alexis Jacquier [France] ; Jean-Claude Deharo [France] ; Eric Chabrière [France] ; Anthony Levasseur [France] ; Florence Fenollar [France] ; Jean-Marc Rolain [France] ; Yolande Obadia [France] ; Philippe Brouqui [France] ; Michel Drancourt [France] ; Bernard La Scola [France] ; Philippe Parola [France] ; Didier Raoult [France] | Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France. |
| 000015 (2020) |
Patricia Schlagenhauf [Suisse] ; Martin P. Grobusch [Pays-Bas] ; Julian D. Maier [Suisse] ; Philippe Gautret [France] | Repurposing antimalarials and other drugs for COVID-19. |
| 000019 (2020) |
Annie Ladoux [France] ; Stéphane Azoulay [France] ; Christian Dani [France] | [SARS-CoV-2 protease: an excellent target to develop drugs against COVID-19]. |
| 000051 (2020) |
Jean-Christophe Lagier [France] ; Matthieu Million [France] ; Philippe Gautret [France] ; Philippe Colson [France] ; Sébastien Cortaredona [France] ; Audrey Giraud-Gatineau [France] ; Stéphane Honoré [France] ; Jean-Yves Gaubert [France] ; Pierre-Edouard Fournier [France] ; Hervé Tissot-Dupont [France] ; Eric Chabrière [France] ; Andreas Stein [France] ; Jean-Claude Deharo [France] ; Florence Fenollar [France] ; Jean-Marc Rolain [France] ; Yolande Obadia [France] ; Alexis Jacquier [France] ; Bernard La Scola [France] ; Philippe Brouqui [France] ; Michel Drancourt [France] ; Philippe Parola [France] ; Didier Raoult [France] | Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis. |
| 000111 (2020) |
M. Plaze [France] ; D. Attali [France] ; A-C Petit [France] ; M. Blatzer [France] ; E. Simon-Loriere [France] ; F. Vinckier [France] ; A. Cachia [France] ; F. Chrétien [France] ; R. Gaillard [France] | [Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study]. |
| 000117 (2020) |
L. Boyer [France] ; P. Auquier [France] ; G. Fond [France] | [Real-life data and Covid-19: The third avenue of reseach]. |
| 000152 (2020) |
H. Javelot [France] ; P-M Llorca [France] ; D. Drapier [France] ; E. Fakra [France] ; C. Hingray [France] ; G. Meyer [France] ; S. Dizet [France] ; A. Egron [France] ; C. Straczek [France] ; M. Roser [France] ; M. Masson [France] ; R. Gaillard [France] ; P. Fossati [France] ; E. Haffen [France] | [Informations on psychotropics and their adaptations for patients suffering from mental disorders in France during the SARS-CoV-2 epidemic]. |
| 000162 (2020) |
S. Touhami [France] ; D. Saadoun [France] ; L. Kodjikian [France] ; B. Bodaghi [France] | [How to approach follow-up of uveitis patients during the Covid-19 pandemic?] |
| 000180 (2020) |
A. Chevance [France] ; D. Gourion [France] ; N. Hoertel [France] ; P-M Llorca [France] ; P. Thomas [France] ; R. Bocher [France] ; M-R Moro [France] ; V. Laprévote [France] ; A. Benyamina [France] ; P. Fossati [France] ; M. Masson [France] ; E. Leaune [France] ; M. Leboyer [France] ; R. Gaillard [France] | [Ensuring mental health care during the SARS-CoV-2 epidemic in France: A narrative review]. |
| 000195 (2020) |
H. Javelot [France] ; P-M Llorca [France] ; G. Meyer [France] ; P. Fossati [France] ; E. Haffen [France] | [Challenges for psychotropics in the context of the SARS-Cov-2 pandemic]. |
| 000249 (2020) |
Elie Rassy [Liban] ; Rita-Maria Khoury-Abboud [Liban] ; Nathalie Ibrahim [Liban] ; Clarisse Kattan [Liban] ; Tarek Assi [Liban] ; Joseph Kattan [Liban] | What the oncologist needs to know about COVID-19 infection in cancer patients. |
| 000321 (2020) |
Erwan Sallard [France] ; François-Xavier Lescure [France] ; Yazdan Yazdanpanah [France] ; France Mentre [France] ; Nathan Peiffer-Smadja [France] | Type 1 interferons as a potential treatment against COVID-19. |
| 000454 (2020) |
Derek C. Angus [États-Unis] ; Scott Berry [États-Unis] ; Roger J. Lewis [États-Unis] ; Farah Al-Beidh [Royaume-Uni] ; Yaseen Arabi [Arabie saoudite] ; Wilma Van Bentum-Puijk ; Zahra Bhimani [Canada] ; Marc Bonten ; Kristine Broglio [États-Unis] ; Frank Brunkhorst [Allemagne] ; Allen C. Cheng [Australie] ; Jean-Daniel Chiche [France] ; Menno De Jong [Pays-Bas] ; Michelle Detry [États-Unis] ; Herman Goossens [Belgique] ; Anthony Gordon [Royaume-Uni] ; Cameron Green [Australie] ; Alisa M. Higgins [Australie] ; Sebastiaan J. Hullegie ; Peter Kruger [Australie] ; Francois Lamontagne [Canada] ; Edward Litton [Australie] ; John Marshall [Canada] ; Anna Mcglothlin [États-Unis] ; Shay Mcguinness [Australie, Nouvelle-Zélande] ; Paul Mouncey [Royaume-Uni] ; Srinivas Murthy [Canada] ; Alistair Nichol [Australie, Irlande (pays)] ; Genevieve K. O'Neill [Australie] ; Rachael Parke [Nouvelle-Zélande] ; Jane Parker [Australie] ; Gernot Rohde [Allemagne] ; Kathryn Rowan [Royaume-Uni] ; Anne Turner [Nouvelle-Zélande] ; Paul Young [Nouvelle-Zélande] ; Lennie Derde [Pays-Bas] ; Colin Mcarthur [Nouvelle-Zélande] ; Steven A. Webb [Australie] | The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and Design. |
| 000456 (2020) |
Edouard Alphandéry [France, Suisse] | The Potential of Various Nanotechnologies for Coronavirus Diagnosis/Treatment Highlighted through a Literature Analysis. |
| 000467 (2020) |
François Danion [France] ; Yvon Ruch [France] ; Marion Fourtage [France] ; Charlotte Kaeuffer [France] ; Valentin Greigert [France] ; Nicolas Lefebvre [France] ; Joris Muller [France] ; Thierry Nai [France] ; Yves Hansmann [France] | The Good, the Bad, and the Hoax: When Publication Instantaneously Impacts Treatment Strategies for COVID-19. |
| 000541 (2020) |
Sebastian E. Sattui [États-Unis] ; Jean W. Liew [États-Unis] ; Elizabeth R. Graef [États-Unis] ; Ariella Coler-Reilly [États-Unis] ; Francis Berenbaum [France] ; Alí Duarte-García [États-Unis] ; Carly Harrison [États-Unis] ; Maximilian F. Konig [États-Unis] ; Peter Korsten [Allemagne] ; Michael S. Putman [États-Unis] ; Philip C. Robinson [Australie] ; Emily Sirotich [Canada] ; Manuel F. Ugarte-Gil [Pérou] ; Kate Webb [Afrique du Sud, Royaume-Uni] ; Kristen J. Young [États-Unis] ; Alfred H J. Kim [États-Unis] ; Jeffrey A. Sparks [États-Unis] | Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19. |
| 000621 (2020) |
Atul Sharma [Australie] ; Swapnil Tiwari [Inde] ; Manas Kanti Deb [Inde] ; Jean Louis Marty [France] | Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies. |
| 000622 (2020) |
Sébastien Nisole [France] ; Aure Saulnier ; Anne Gatignol [Canada] | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease? |
| 000700 (2020) |
Daria Sicari [France, Italie] ; Aristotelis Chatziioannou [Grèce] ; Theodoros Koutsandreas [Grèce] ; Roberto Sitia [Italie] ; Eric Chevet [France, Italie] | Role of the early secretory pathway in SARS-CoV-2 infection. |
| 000718 (2020) |
P C Fragkou [Suisse] ; D. Belhadi [France] ; N. Peiffer-Smadja [France] ; C D Moschopoulos [Grèce] ; F-X Lescure [France] ; H. Janocha [Allemagne] ; E. Karofylakis [Grèce] ; Y. Yazdanpanah [France] ; F. Mentré [France] ; C. Skevaki [Allemagne] ; C. Laouénan [France] ; S. Tsiodras [Suisse] | Review of trials currently testing treatment and prevention of COVID-19. |
| 000759 (2020) |
M. Plaze [France] ; D. Attali [France] ; A-C Petit [France] ; M. Blatzer [France] ; E. Simon-Loriere [France] ; F. Vinckier [France] ; A. Cachia [France] ; F. Chrétien [France] ; R. Gaillard [France] | Repurposing chlorpromazine to treat COVID-19: The reCoVery study. |
